Find your path to Florian
29 people in our graph share verified history with Florian — schools, employers, funds. One of them is your warm intro.
About
Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund. Before joining NVF, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and previously held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity within early clinical research. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Board seats
AnaveonCitryllLoQus23 TherapeuticsONL TherapeuticsRhyGazeSalvinaSpliceBio
Per the firm's website.
Colleagues at Novartis Venture Fund
Frequently asked questions
- Who is Florian Müellershausen?
- Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund. Before joining NVF, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and previously held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity within early clinical research. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.
- Where does Florian Müellershausen work?
- Florian Müellershausen is Managing Director at Novartis Venture Fund.
- What does Florian Müellershausen invest in?
- Florian Müellershausen invests in Biotech.
- What boards does Florian Müellershausen sit on?
- Florian Müellershausen holds tracked board seats at Anaveon, Citryll, LoQus23 Therapeutics, ONL Therapeutics, RhyGaze, Salvina, SpliceBio.